EX1 0.00% 1.1¢ exopharm limited

Ann: Quarterly Activities Report and Appendix 4C, page-31

  1. 6,030 Posts.
    lightbulb Created with Sketch. 26
    The good news is that they have $3.9m from a r & d rebate not included in last quarterly. So I think the quarterly in terms of cash left will surprise on the upside
 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.